Related Experiment Videos

[Cardiovascular repercussions of chronic hemodialysis]

A P Guérin1, S J Marchais, F Métivier

  • 1Centre hospitalier FH Manhes, Fleury-Mérogis.

La Revue Du Praticien
|March 1, 1990
PubMed

Insights

Coronary heart disease and left ventricular failure are leading causes of death in patients undergoing haemodialysis. Uraemic cardiopathy, characterized by specific cardiac changes, contributes to these outcomes in dialysis patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Context:

  • Haemodialysis patients face high mortality rates from coronary disease and left ventricular failure.
  • Cardiovascular complications in this population are often linked to a multifactorial risk profile rather than solely accelerated atherosclerosis.
  • Diagnosing coronary disease in haemodialysis patients can be challenging.

Purpose:

  • To describe the characteristics of "uraemic cardiopathy" in haemodialysis patients.
  • To differentiate the etiology of coronary disease in this cohort from typical accelerated atherogenesis.
  • To highlight the specific cardiac structural and functional alterations observed.

Summary:

  • "Uraemic cardiopathy" presents as left ventricular dilatation with increased myocardial mass but a low mass/volume ratio, irrespective of prior cardiovascular history.
  • Systolic function is generally preserved.
  • Diastolic compliance is impaired due to left ventricular hypertrophy.

Impact:

  • Provides a clearer understanding of cardiac pathology in haemodialysis patients.
  • Aids in the diagnosis and management of cardiovascular complications in this high-risk group.
  • Highlights the importance of addressing "uraemic cardiopathy" in clinical practice.

Related Concept Videos